CVS Health Files Q2 2024 10-Q
Ticker: CVS · Form: 10-Q · Filed: 2024-08-07T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, quarterly-report, healthcare, retail
TL;DR
CVS Health's Q2 2024 10-Q is in. Check financials.
AI Summary
CVS Health Corp. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarter of 2024. Key financial figures and business segment information are presented, reflecting the company's ongoing activities in retail pharmacy and healthcare services.
Why It Matters
This filing provides investors and analysts with the latest financial performance data for CVS Health, crucial for understanding the company's current health and future prospects.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial disclosures.
Key Numbers
- 20240630 — Period End Date (Indicates the end of the reporting quarter.)
- 20240807 — Filing Date (The date the report was officially submitted to the SEC.)
Key Players & Entities
- CVS HEALTH Corp (company) — Filer
- 20240630 (date) — Period of Report
- 20240807 (date) — Filing Date
- 0000064803 (company) — Central Index Key
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20240630, meaning the filing covers the period ending June 30, 2024.
When was this 10-Q filed with the SEC?
The filing date (FILED AS OF DATE) is 20240807.
What is the Central Index Key (CIK) for CVS HEALTH Corp?
The Central Index Key for CVS HEALTH Corp is 0000064803.
What is the Standard Industrial Classification (SIC) code for CVS HEALTH Corp?
The SIC code is RETAIL-DRUG STORES AND PROPRIETARY STORES [5912].
What is the fiscal year end for CVS HEALTH Corp?
The fiscal year end for CVS HEALTH Corp is 1231.
From the Filing
0000064803-24-000029.txt : 20240807 0000064803-24-000029.hdr.sgml : 20240807 20240807063529 ACCESSION NUMBER: 0000064803-24-000029 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 95 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240807 DATE AS OF CHANGE: 20240807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CVS HEALTH Corp CENTRAL INDEX KEY: 0000064803 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 050494040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-01011 FILM NUMBER: 241181321 BUSINESS ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 BUSINESS PHONE: 4017651500 MAIL ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 FORMER COMPANY: FORMER CONFORMED NAME: CVS CAREMARK CORP DATE OF NAME CHANGE: 20070509 FORMER COMPANY: FORMER CONFORMED NAME: CVS/CAREMARK CORP DATE OF NAME CHANGE: 20070322 FORMER COMPANY: FORMER CONFORMED NAME: CVS CORP DATE OF NAME CHANGE: 19970128 10-Q 1 cvs-20240630.htm 10-Q cvs-20240630 0000064803 12/31 2024 Q2 false http://fasb.org/us-gaap/2024#ProductMember http://fasb.org/us-gaap/2024#ProductMember http://fasb.org/us-gaap/2024#ProductMember http://fasb.org/us-gaap/2024#ProductMember http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligations http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligations xbrli:shares iso4217:USD iso4217:USD xbrli:shares cvs:store cvs:clinic cvs:people cvs:patient cvs:Segment cvs:state cvs:business xbrli:pure cvs:security cvs:lease 0000064803 2024-01-01 2024-06-30 0000064803 2024-07-31 0000064803 us-gaap:ProductMember 2024-04-01 2024-06-30 0000064803 us-gaap:ProductMember 2023-04-01 2023-06-30 0000064803 us-gaap:ProductMember 2024-01-01 2024-06-30 0000064803 us-gaap:ProductMember 2023-01-01 2023-06-30 0000064803 2024-04-01 2024-06-30 0000064803 2023-04-01 2023-06-30 0000064803 2023-01-01 2023-06-30 0000064803 us-gaap:ServiceMember 2024-04-01 2024-06-30 0000064803 us-gaap:ServiceMember 2023-04-01 2023-06-30 0000064803 us-gaap:ServiceMember 2024-01-01 2024-06-30 0000064803 us-gaap:ServiceMember 2023-01-01 2023-06-30 0000064803 2024-06-30 0000064803 2023-12-31 0000064803 2022-12-31 0000064803 2023-06-30 0000064803 us-gaap:CommonStockMember 2023-12-31 0000064803 us-gaap:TreasuryStockCommonMember 2023-12-31 0000064803 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-12-31 0000064803 us-gaap:RetainedEarningsMember 2023-12-31 0000064803 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000064803 us-gaap:ParentMember 2023-12-31 0000064803 us-gaap:NoncontrollingInterestMember 2023-12-31 0000064803 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000064803 us-gaap:ParentMember 2024-01-01 2024-03-31 0000064803 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0000064803 2024-01-01 2024-03-31 0000064803 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000064803 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000064803 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000064803 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0000064803 us-gaap:CommonStockMember 2024-03-31 0000064803 us-gaap:TreasuryStockCommonMember 2024-03-31 0000064803 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2024-03-31 0000064803 us-gaap:RetainedEarningsMember 2024-03-31 0000064803 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000064803 us-gaap:ParentMember 2024-03-31 0000064803 us-gaap:NoncontrollingInterestMember 2024-03-31 0000064803 2024-03-31 0000064803 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0000064803 us-gaap:ParentMember 2024-04-01 2024-06-30 0000064803 us-gaap:NoncontrollingInterestMember 2024-04-01 2024-06-30 0000064803 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0000064803 us-gaap:CommonStockMember 2024